OCTIMET Oncology NV
Industry
- Pharmaceuticals
- Biotechnology
See more in Biomedtracker
Latest on OCTIMET Oncology NV
Scrip
• By Ian Haydock, Joseph Haas, and Jung Won Shin
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Junshi Gets Four Cancer Candidates From
Scrip
• By Deanna Kamienski, Beth Allan, Maureen Riordan, and Steven Muntner
Abbisko Therapeutics Abbisko brings in $28mm via Series A China-based Abbisko Therapeutics raised $28mm through its Series A financing to Lilly Asia Ventures, Sinopharm Capital, Jianxin Capita